Literature DB >> 17289873

Expression of voltage-gated potassium channels in human and mouse colonic carcinoma.

Jiraporn Ousingsawat1, Melanie Spitzner, Supaporn Puntheeranurak, Luigi Terracciano, Luigi Tornillo, Lukas Bubendorf, Karl Kunzelmann, Rainer Schreiber.   

Abstract

PURPOSE: Voltage-gated Kv potassium channels, like ether a go-go (EAG) channels, have been recognized for their oncogenic potential in breast cancer and other malignant tumors. EXPERIMENTAL
DESIGN: We examined the molecular and functional expression of Kv channels in human colonic cancers and colon of mice treated with the chemical carcinogens dimethylhydrazine and N-methyl-N-nitrosourea. The data were compared with results from control mice and animals with chemically induced DSS colitis.
RESULTS: Electrogenic salt transport by amiloride-sensitive Na+ channels and cyclic AMP-activated cystic fibrosis transmembrane conductance regulator Cl- channels were attenuated during tumor development and colitis, whereas Ca2+-dependent transport remained unchanged. Kv channels, in particular Eag-1, were enhanced during carcinogenesis. Multiplex reverse transcription-PCR showed increased mRNA expression for Kv1.3, Kv1.5, Kv3.1, and members of the Eag channel family, after dimethylhydrazine and N-methyl-N-nitrosourea treatment. Eag-1 protein was detected in the malignant mouse colon and human colonic cancers. Genomic amplification of Eag-1 was found in 3.4% of all human colorectal adenocarcinoma and was an independent marker of adverse prognosis.
CONCLUSIONS: The study predicts an oncogenic role of Kv and Eag channels for the development of colonic cancer. These channels may represent an important target for a novel pharmacotherapy of colonic cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289873     DOI: 10.1158/1078-0432.CCR-06-1940

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  55 in total

1.  Up-regulation of Kv7.1 channels in thromboxane A2-induced colonic cancer cell proliferation.

Authors:  Takahiro Shimizu; Takuto Fujii; Yuji Takahashi; Yuta Takahashi; Tomoyuki Suzuki; Masashi Ukai; Katsunori Tauchi; Naoki Horikawa; Kazuhiro Tsukada; Hideki Sakai
Journal:  Pflugers Arch       Date:  2013-09-01       Impact factor: 3.657

2.  Differential Expression of Ion Channels and Transporters During Hepatocellular Carcinoma Development.

Authors:  Violeta Zúñiga-García; María de Guadalupe Chávez-López; Valeria Quintanar-Jurado; Nayeli Belem Gabiño-López; Elisabeth Hernández-Gallegos; Juan Soriano-Rosas; Julio Isael Pérez-Carreón; Javier Camacho
Journal:  Dig Dis Sci       Date:  2015-04-05       Impact factor: 3.199

Review 3.  New Insights into the Functions of Nucleic Acids Controlled by Cellular Microenvironments.

Authors:  Saki Matsumoto; Naoki Sugimoto
Journal:  Top Curr Chem (Cham)       Date:  2021-03-30

4.  Genistein and tyrphostin AG556 decrease ultra-rapidly activating delayed rectifier K+ current of human atria by inhibiting EGF receptor tyrosine kinase.

Authors:  Guo-Sheng Xiao; Yan-Hui Zhang; Wei Wu; Hai-Ying Sun; Yan Wang; Gui-Rong Li
Journal:  Br J Pharmacol       Date:  2017-02-09       Impact factor: 8.739

5.  Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC.

Authors:  María de Guadalupe Chávez-López; Julio Isael Pérez-Carreón; Violeta Zuñiga-García; José Díaz-Chávez; Luis A Herrera; Claudia Haydee Caro-Sánchez; Isabel Acuña-Macías; Patricio Gariglio; Elizabeth Hernández-Gallegos; Andrea Jazmín Chiliquinga; Javier Camacho
Journal:  Tumour Biol       Date:  2015-03-18

Review 6.  The roles of K(+) channels in cancer.

Authors:  Luis A Pardo; Walter Stühmer
Journal:  Nat Rev Cancer       Date:  2013-12-12       Impact factor: 60.716

Review 7.  Ion channels: functional expression and therapeutic potential in cancer. Colloquium on Ion Channels and Cancer.

Authors:  Scott P Fraser; Luis A Pardo
Journal:  EMBO Rep       Date:  2008-05-02       Impact factor: 8.807

8.  Identifying regulators for EAG1 channels with a novel electrophysiology and tryptophan fluorescence based screen.

Authors:  Tinatin I Brelidze; Anne E Carlson; Douglas R Davies; Lance J Stewart; William N Zagotta
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

Review 9.  Voltage-gated potassium channels as therapeutic targets.

Authors:  Heike Wulff; Neil A Castle; Luis A Pardo
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

Review 10.  Kv10.1 K(+) channel: from physiology to cancer.

Authors:  Halima Ouadid-Ahidouch; Ahmed Ahidouch; Luis A Pardo
Journal:  Pflugers Arch       Date:  2016-01-08       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.